Radiotherapy hypofractionation in early breast cancer

The Lancet

Volumn 372, Issue 9634, 2008, Pages 204-205

  Carling, Margaret ^a   Goodare, Heather ^a   Ironside, Audrey ^a   Millington, Jan ^a   Rogers, Christina ^a  

^a RAGE (Radiotherapy Action Group Exposure)   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL TRIAL; FOLLOW UP; HUMAN; LETTER; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SOCIAL CARE; TREATMENT OUTCOME; BREAST TUMOR; FEMALE; NOTE; PSYCHOLOGICAL ASPECT; TIME;

BREAST NEOPLASMS; DOSE FRACTIONATION; FEMALE; HUMANS; QUALITY OF LIFE; RADIATION INJURIES; TIME FACTORS;

EID: 47149101132     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61067-3     Document Type: Letter

References (5)

1. The START Trialists' Group. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 371 (2008) 1098-1107
2. The START Trialists' Group. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 9 (2008) 331-341
3. Bartelink H., and Arriagada R. Hypofractionation in radiotherapy for breast cancer. Lancet 371 (2008) 1050-1052
4. Withers H. Radiation biology and treatment options in radiation oncology. Cancer Res 59 suppl (1999) 1676s-1684s
5. Hopwood P., Haviland J., Mills J., Sumo G., and Bliss J. The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial). Breast 16 (2007) 241-251